| Characteristic | Number of agents |
|---|---|
| Small molecule - direct acting | 115 |
| Peptide - direct acting | 33 |
| Bacteriophage/Bacteriophage products | 29 |
| Small molecule - indirect acting | 23 |
| Large molecule - direct acting | 17 |
| Immunomodulators | 9 |
| Biologic (Antibody or other biotherapeutic) | 7 |
| Large molecule - indirect acting | 3 |
| Microbiome modifying agents | 3 |
| Decolonization agents | 3 |
| Peptide - indirect acting | 1 |
| Nucleic acid based product | 1 |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
June 2024
More information
Region
Worldwide
Survey time period
2023
Supplementary notes
The analysis does not include: vaccines; topical decolonizing agents; non-specific inorganic substances; biodefence agents; agents not developed for systemic use (injectable or oral formulations) or inhalation but only for topical application (e.g., creams or eye drops); new formulations of existing treatments; or extension of indication of already approved antibacterial agents.
Citation formats
